Business · 14. 11. 2026.1 min read
CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List
Локални аутоматски превод · Изворни језик извора
Сажетак
SHANGHAI, Nov. 14, 2026 — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that satricabtagene autoleucel…
Изворни језик извора: PR Newswire — Global News ReleasesПрочитајте оригинал →